Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer

NCT06417476 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Rectal Neoplasms

Interventions

RADIATION: Short-course radiotherapy
DRUG: Irinotecan
DRUG: Oxaliplatin
DRUG: Calcium Formate
DRUG: Fluorouracil
RADIATION: Long-course chemoradiation
DRUG: Capecitabine

Sponsor

Pei-Rong Ding

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]